Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.40 is 200% below its 5-year average of -0.13, near the low end of its 5-year range (-0.40–-0.02).
As of the fiscal period ended Tuesday, June 30, 2026. 92.54% below its 12-month average of -0.21.
Reported quarterly EPS; no daily interpolation. Q4 FY2026 (2026-06-30): -0.02.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:25:27.616Z. Historical observations retain their original dates. Historical series through 2025-08-28.
EARNINGS PER SHARE (EPS)
-0.40
EARNINGS PER SHARE (EPS) AVG TTM
-0.21
EARNINGS PER SHARE (EPS) AVG 3Y
-0.17
EARNINGS PER SHARE (EPS) AVG 5Y
-0.13
EARNINGS PER SHARE (EPS) AVG 10Y
-0.17
EARNINGS PER SHARE (EPS) AVG 15Y
-0.24
EARNINGS PER SHARE (EPS) AVG 20Y
-0.19
CURRENT VS TTM AVG
-92.54%
CURRENT VS 3Y AVG
-137.64%
CURRENT VS 5Y AVG
-200.00%
CURRENT VS 10Y AVG
-130.68%
CURRENT VS 15Y AVG
-68.30%
CURRENT VS 20Y AVG
-115.03%
Accuray Incorporated
Market Cap
$35.89M
Earnings Per Share (EPS)
-0.40
TTM Avg
-0.21
3Y Avg
-0.17
5Y Avg
-0.13
Market Cap
$36.05M
Earnings Per Share (EPS)
-1.96
TTM Avg
-0.82
3Y Avg
-0.31
5Y Avg
-0.18
Market Cap
$36.31M
Earnings Per Share (EPS)
-0.52
TTM Avg
-0.68
3Y Avg
-0.92
5Y Avg
-0.73
Market Cap
$36.32M
Earnings Per Share (EPS)
0.94
TTM Avg
-0.29
3Y Avg
-1.25
5Y Avg
-1.59
Market Cap
$36.37M
Earnings Per Share (EPS)
-13.84
TTM Avg
-117.78
3Y Avg
-126.66
5Y Avg
-275.31
Market Cap
$36.61M
Earnings Per Share (EPS)
-2.13
TTM Avg
-3.42
3Y Avg
-5.72
5Y Avg
-5.72
Market Cap
$37.67M
Earnings Per Share (EPS)
-1.69
TTM Avg
-1.60
3Y Avg
-3.62
5Y Avg
-4.57
Market Cap
$33.52M
Earnings Per Share (EPS)
-1.26
TTM Avg
-0.80
3Y Avg
-2.79
5Y Avg
-3.86
Market Cap
$38.34M
Earnings Per Share (EPS)
-2.33
TTM Avg
-7.80
3Y Avg
-4.68
5Y Avg
-3.46
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Accuray Incorporated (ARAY) | $35.89M | -0.40 | -0.21 | -0.17 | -0.13 |
| DocGo Inc. (DCGO)vs › | $36.05M | -1.96 | -0.82 | -0.31 | -0.18 |
| HeartBeam, Inc. (BEAT)vs › | $36.31M | -0.52 | -0.68 | -0.92 | -0.73 |
| Elutia Inc (ELUT)vs › | $36.32M | 0.94 | -0.29 | -1.25 | -1.59 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $36.37M | -13.84 | -117.78 | -126.66 | -275.31 |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.61M | -2.13 | -3.42 | -5.72 | -5.72 |
| Edesa Biotech, Inc. (EDSA)vs › | $37.67M | -1.69 | -1.60 | -3.62 | -4.57 |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.52M | -1.26 | -0.80 | -2.79 | -3.86 |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.34M | -2.33 | -7.80 | -4.68 | -3.46 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.42M | -7.30 | -11.70 | -7.29 | -5.93 |
Trailing EPS (TTM)
$-0.40
Forward EPS (Est.)
$-0.24
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-06-30 | -0.40 |
| 2025-06-30 | -0.02 |
| 2024-06-30 | -0.16 |
| 2023-06-30 | -0.10 |
| 2022-06-30 | -0.06 |
| 2021-06-30 | -0.07 |
| 2020-06-30 | 0.04 |
| 2019-06-30 | -0.19 |
| 2018-06-30 | -0.28 |
| 2017-06-30 | -0.36 |
| 2016-06-30 | -0.32 |
| 2015-06-30 | -0.51 |
| 2014-06-30 | -0.47 |
| 2013-06-30 | -1.41 |
| 2012-06-30 | -1.02 |
| 2011-06-30 | -0.44 |
| 2010-06-30 | 0.05 |
| 2009-06-30 | 0.01 |
| 2008-06-30 | 0.10 |
| 2007-06-30 | -0.18 |
| 2006-06-30 | -2.11 |
| 2005-06-30 | -1.76 |
| 2004-06-30 | -1.00 |
| 2003-06-30 | -1.49 |
| 2002-06-30 | -1.21 |
